Retinoic Acid Receptor alpha Antikörper (C-Term)

Produktnummer ABIN185366

Produktdetails anti-Retinoic Acid Receptor alpha Antikörper

Target: Retinoic Acid Receptor alpha (RARA) (Retinoic Acid Receptor, alpha (RARA))

Bindungsspezifität: C-Term

Reaktivität: Human

Wirt: Ziege

Klonalität: Polyklonal

Konjugat: Dieser Retinoic Acid Receptor alpha Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA

Verwendungszweck: RARA

Sequenz: SPSLSPSSHR SSPATQSP

Spezifität: This antibody is expected to recognize all three reported isoforms (NP_000955.1, NP_001019980.1, NP_001138774.1 ). Please note the epitope is from the mouse/rat sequence. Human sequence is SPSLSPSSNRSSPATHSP and thus highly similar. Reported variants NP_0

Kreuzreaktivität: Rind (Kuh), Hund, Human, Maus, Ratte

Aufreinigung: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Güteklasse: Verified

Immunogen: Peptide with sequence C-SPSLSPSSHRSSPATQSP, from the C Terminus of the protein sequence according to NP_000955.1, NP_001138773.1, NP_001019980.1, NP_001138774.1.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise:

Western Blot: Approx 55 kDa band observed in Human Breast and Breast cancer lysates (calculated MW of 50.8 kDa according to NP_000955.1and NP_001019980.1). Recommended concentration: 0.5-2 μg/mL.

Peptide ELISA: antibody detection limit dilution 1:8000.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.5 mg/mL

Buffer: Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Minimize freezing and thawing.

Lagerung: -20 °C

Informationen zur Lagerung: Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.

Details zu Retinoic Acid Receptor alpha

Target: Retinoic Acid Receptor alpha (RARA) (Retinoic Acid Receptor, alpha (RARA))

Andere Bezeichnung: RARA (RARA Produkte)

Synonyme: NR1B1 antikoerper, RAR antikoerper, Nr1b1 antikoerper, RARalpha1 antikoerper, rar-alpha antikoerper, etID309833.12 antikoerper, rara antikoerper, rara2a antikoerper, zRAR antikoerper, zRAR-alpha antikoerper, zgc:109797 antikoerper, nr1b1 antikoerper, RAR-ALPHA1 antikoerper, HS-RARa antikoerper, fj66e06 antikoerper, rara2b antikoerper, wu:fj66e06 antikoerper, retinoic acid receptor alpha antikoerper, retinoic acid receptor, alpha antikoerper, retinoic acid receptor, alpha a antikoerper, retinoic acid receptor alpha L homeolog antikoerper, retinoic acid receptor, alpha b antikoerper, RARA antikoerper, Rara antikoerper, LOC100136372 antikoerper, raraa antikoerper, rara.L antikoerper, rara antikoerper, rarab antikoerper

Hintergrund: RARA, RAR, NR1B1, retinoic acid receptor, alpha, Retinoic acid receptor, alpha polypeptide, nucleophosmin-retinoic acid receptor alpha fusion protein NPM-RAR long form, nucleophosmin-retinoic acid receptor alpha fusion protein NPM-RAR short form

Gen-ID: 5914

NCBI Accession: NP_000955, NP_001138773, NP_001019980, NP_001138774

Pathways: Nuclear Receptor Transcription Pathway, Retinoic Acid Receptor Signaling Pathway, Intracellular Steroid Hormone Receptor Signaling Pathway, Steroid Hormone Mediated Signaling Pathway, Cellular Response to Molecule of Bacterial Origin, Positive Regulation of Immune Effector Process, S100 Proteine